The Correlations of Plasma and Cerebrospinal Fluid Amyloid-Beta Levels with Platelet Count in Patients with Alzheimer’s Disease
Table 1
Characteristics of the study population.
CON (n=61)
AD (n=58)
PIB-PET(+)-AD (n=18)
P1 value (AD vs. CON)
P2 value (PET vs. CON)
Age (years)
69.16±11.55
71.52±10.71
68.22±8.00
0.252
0.748
Female (%)
30 (49.18)
30 (51.72)
9 (50.00)
0.781
0.951
Education years
9.13±3.58
7.89±4.42
9.56±4.59
0.225
0.550
Hypertension (%)
14 (22.95)
11 (18.97)
3 (16.67)
0.594
0.807
Diabetes mellitus (%)
2 (3.28)
4 (6.90)
0
0.629
>0.999
Cardiovascular disease (%)
9 (14.75)
5 (8.62)
1 (5.56)
0.299
0.530
Hyperlipidemia (%)
5 (8.20)
4 (6.90)
0
>0.999
0.481
Platelet count
162.57±53.00
168.97±44.32
178.22±53.40
0.478
0.275
MMSE
27.17±2.75
16.48±6.51
12.17±5.76
<0.001
<0.001
CDR
0
1.86±0.86
2.08±0.88
<0.001
<0.001
Data given as mean ± SD unless otherwise stated. MMSE, Minimental State Examination; CDR, Clinical Dementia Rating. P value, two-tailed independent t-tests, Mann-Whitney U test, or Chi-square test as appropriate.
